RT Journal Article
SR Electronic
T1 395 Enhancement of bispecific T cell engagers (bispecific TCE) killing potency in AML with the neximmune artificial immune modulation (AIM™) adoptive cell therapy (ACT) T cells
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A443
OP A443
DO 10.1136/jitc-2023-SITC2023.0395
VO 11
IS Suppl 1
A1 Wang, Ruipeng
A1 Oelke, Mathias
A1 Jain, Shweta
A1 Kim, Sojung
A1 Ragheb, Jack
A1 Parks, Adam
A1 Wang, Rui
A1 Reed, Charles
A1 Alvarez, Brian
A1 Zeldis, Jerome
A1 Bednarik, Daniel
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A443.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.